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1. Summary 
1.1 Summary 
The understanding of pathogen host interactions is crucial for the development of vaccines 
and therapeutics against infectious diseases. Prerequisites for studying such interactions are 
appropriate techniques and tools. For example, monitoring a virus` life cycle is possible with 
several microscopy techniques. But since viruses are to small to be seen with most of the 
existing microscopes, they have to be modified. A commonly used technique is labelling of 
the virus with a fluorescent dye or protein. Such reporter-viruses can be generated by a 
chemical modification or by a genetic alteration of the virus genome.  
 
This work aimed at the generation of an infectious laryngotracheitis (ILT) reporter virus, that 
will enable a real time monitoring of host cell infections. For this purpose, protein fragments 
of ILTV were fused to a fluorescent protein (mNeonGreen; mNG). Furthermore, cell lines 
were generated that stably express this fusion protein and provide it in trans to facilitate the 
incorporation into newly build ILT particles.   
 
This reporter virus should enable new insights into the infection pathway of ILTV and thus 
will be important for combating the epizootic disease which causes immense economic losses 
in poultry production worldwide. 
 
Keywords: Infectious laryngotracheitis virus, GaHV-1, reporter virus, mNeonGreen, stable 
cell line 
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1.2 Zusammenfassung 
Eine Voraussetzung zur Entwicklung von Impfungen und Therapien gegen 
Infektionskrankheiten ist das grundlegende Verständnis der Pathogen-Wirt-Interaktionen. 
Zum Studium dieser Interaktionen sind geeignete Methoden und Werkzeuge erforderlich. 
Durch verschiedene Mikroskopie-Techniken lassen sich z.B. virale Infektionswege verfolgen. 
Viren sind jedoch zu klein, um für die meisten bildgebenden Verfahren sichtbar zu sein. 
Daher müssen sie modifiziert werden. Eine gängige Methode ist die Markierung mittels 
fluoreszierendem Farbstoff oder Protein. Solche Reporter-Viren können durch chemische 
oder genetische Modifikation des Virusgenoms erzeugt werden. 
 
Die hier vorgestellte Arbeit hatte das Ziel, ein Reporter-Virus, basierend auf dem Infektiösen 
Laryngotracheitis (ILT) Virus, herzustellen, welches die Echtzeit-Beobachtung der Infektion 
von Zellen ermöglichen soll. Dazu wurden Fragmente eines ILTV Proteins mit einem 
fluoreszierenden Protein (mNeonGreen; mNG) fusioniert. Des Weiteren wurden Zelllinien 
generiert, welche diese Fusionsproteine stabil exprimieren und dadurch in trans zur 
Verfügung stellen, um deren Inkorporation in neugebildete ILT Partikel zu ermöglichen. 
 
Dieses Reporter-Virus soll neue Einblicke in den Infektionszyklus von ILTV liefern und ist 
daher wichtig für die Bekämpfung der Tierseuche, die weltweit immense ökonomische 
Verluste in der Geflügelproduktion verursacht. 
 
Stichworte: Infektiöses Laryngotracheitis Virus, GaHV-1, reporter virus, mNeonGreen, 
stabile Zelllinie 
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2. Introduction 
Infectious laryngotracheitis caused by the homonymous virus, also known as 
Gallid alphaherpesvirus 1, is a worldwide occurring, highly contagious, respiratory disease 
with a narrow host range. Susceptible species are chicken, pheasants and peafowls [1]. 
Infected animals show symptoms ranging from conjunctivitis and serous nasal discharge to 
haemorrhagic tracheitis with dyspnoea and expectoration of sanguineous mucus [2], [3]. In 
severe cases, 5% to 72% of infected animals will die [4]. But even without severe symptoms, 
ILTV infection leads to reduced weight gain and decreased egg production which has a huge 
economic impact [5]. Animals surviving the acute phase lasting for 1 to 2 weeks [4], still 
harbour the virus in a latent state, mainly in the trigeminal ganglion [6]. Immunosuppressive 
and stressful circumstances can lead to a reactivation of the virus and thus shedding of 
infectious particles [7], which can be a threat for other susceptible birds.   
 
Today the clinical manifestation of ILT is well known. Furthermore, the virus life cycle is 
characterized on the level of target organs and tissues. Virus replication primary takes place 
in the tracheal tissue, however, other mucus membranes like conjunctiva, respiratory sinuses, 
air sacs and the lung can be infected as well [5], [8]. Even though a lot is known about the 
basic biology of ILTV, a detailed understanding of the cellular mechanisms during infection, 
like cell entry, replication and egress of ILTV, is not yet entirely revealed. A more precise 
picture of ILTV-host interactions could help to improve intervention strategies.  
 
Currently no specific treatment against ILT is possible. For controlling the disease, various 
vaccines are available and are applied in several countries worldwide. One drawback of these 
vaccines is the challenge to differentiate between field isolates and vaccination strains, which 
is not possible with routine diagnostic methods. Furthermore, the commonly used live 
attenuated virus vaccines bear the risk of reversion and recombination with field strains due 
to latency [9], [10], [11].  
 
The development of safe DIVA-vaccines (Differentiating Infected from Vaccinated Animals) 
is in high demand, since the serious and significant effects of ILT in animal welfare and 
economics. To achieve this, it is crucial to understand the virus’ interaction with its host cells. 
To gain further insights, reporter viruses have been shown to operate as a useful tool to 
visualize various events of the viral life cycle [12], [13]. Fluorescently labelled viruses even 
allow for real time monitoring of certain infection steps and may help to understand those 
mechanisms in more detail.  
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2.1 Infectious Laryngotracheitis Virus  
2.1.1 Taxonomy 
ILTV belongs to the family Herpesviridae, subfamily Alphaherpesvirinae [14], [15]. 
Alphaherpesviruses are divided into six genera. GaHV-1 and the Psittacid alphaherpesvirus 1 
(PsHV-1), the causative pathogen of Pacheco’s disease in psittacine birds, are the only two 
members assigned to the genus Iltovirus (Fig. 1). Iltoviruses represent a phylogenetically 
unique class of alphaherpesviruses analysed by comparison of nucleotide sequence, gene 
content and genomic organization [14], [16]. ILTV exhibits a considerable evolutionary 
distance from most other avian and mammalian alphaherpesviruses [14], [16], [17]. 
 
 
 
 
 
FIG. 1. Phylogenetic tree of Herpesviridae. Stacy et al., VetMicrobiol., 2008 
Demonstration of considerable distance of GaHV-1 (marked with a star) to other avian and 
mammalian herpesviruses apart from PsHV-1 which is also assigned to the genus Iltovirus 
within the subfamily Alphaherpesvirinae. 
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2.1.2 Morphology and genome organization 
The ILTV genome consists of a linear double-stranded DNA molecule [5], 148,665 base 
pairs (bp) in length [14]. The icosahedral nucleocapsid measures 80 – 100 nm in diameter 
and is surrounded by various tegument proteins. The irregular envelope is spiked with 
characteristic glycoproteins and measures 195 – 250 nm in diameter (Fig. 2) [5]. 
 
 
 
Most of the designations for open reading frames (ORFs) and proteins of ILTV were adopted 
from the homologues in herpes simplex virus type 1 (HSV-1) [18], [19]. The ILTV genome 
compromises two domains of unique sequences, the unique short (US) region and the unique 
long (UL) region. Only the US region is flanked by internal repeats and terminal repeats, 
respectively [14], [20], allowing the existence of two isomeric forms with an inversion of the 
US region only [21]. This specific genome structure classifies the ILTV genome as a class D 
herpesvirus genome [14]. Altogether 77 ORFs were predicted along the ILTV genome [14]. 
The UL region contains 62 genes and includes a block of five unique, conserved ORFs (A to 
E, Fig. 3, marked with circles) [14]. An additional characteristic for ILTV’s UL region is an 
inversion from UL22 to UL44 (Fig. 3, marked with stars) [14], [22], [23]. No homologue of 
UL16 could be found in the ILTV genome. The US region contains 9 genes and is flanked by 
FIG. 2. Scheme of ILTV morphology. 
The linear double stranded DNA is located in the icosahedral nucleocapsid, which is itself 
wrapped in a proteinaceous layer (tegument) and a lipid bilayer called envelope. The envelope is 
spiked with various glycoproteins. The whole viral particle measures 195 to 250 nm in diameter.  
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the inverted repeat regions containing two copies of the genes: ICP4, US10 and SORF4/3 
(Fig. 3, marked with triangles). Five structural glycoproteins were predicted to be encoded by 
the US region [14].  
 
 
 
 
 
 
FIG. 3. Scheme of GaHV-1 genome content [5]. 
The five conserved, unique ORFs are marked with circles. The three genes in copy within the 
inverted repeats are marked with triangles. The stars indicate the inversion of the genome 
region from UL22 to UL44. The rectangle marks the SORF1 gene, encoding the abundant 
tegument phosphoprotein UL47. 
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2.1.3 ILTV UL47 
In comparison with most alphaherpesviruses, the UL47 gene (also SORF1) of ILTV and 
PsHV-1 is translocated from the UL region to the US region (Fig. 3, marked with a 
rectangle). It is located between the conserved genes US3 (protein kinase) and US4 
(glycoprotein G) [14], [22], [24], [25]. The ILTV UL47 gene encodes for an abundant 
tegument phosphoprotein [24]. The role of UL47 during infection is not yet investigated 
properly. In HSV-1, pseudorabies virus (PrV) and Marek’s disease virus serotype 1 (MDV-1, 
renamed to gallid alphaherpesvirus 2), UL47 seems to be non-essential for replication in vitro 
[26], [27], [28]. Nevertheless, adverse effects were observed: reduced plaque sizes formed by 
PrV- and MDV-1-ΔUL47 viruses [26], [27], smaller and less electron-dense tegument 
surrounding the capsids produced by PrV-ΔUL47 mutants [27], and severe growth 
impairment in MDV-1 strains with a deletion of the UL47 gene [26]. Furthermore, deletion 
of the UL47 gene in PrV led to an impairment of the secondary envelopment with subsequent 
accumulation of tegumented capsids within the cytoplasm [27]. Beyond that, it led to a 
moderate attenuation in experimentally infected mice in correlation with a slower 
neuroinvasion rate and influence on neurovirulence [29]. 
 
Aiming at the development of safer vaccines against ILTV, construction of virus mutants 
bearing a deletion of a particular gene could be a conceivable approach. In case of UL47, 
Helferich et al. investigated the growth properties of ILTV mutants lacking the UL47 gene in 
vitro and the relevance for virulence and immunogenicity in vivo [24]. Similar to PrV and 
MDV-1, they could reveal that ILTV UL47 is not essential for in vitro replication. 
Furthermore, plaque size was reduced by 95% compared to wild type ILTV and maximum 
titre was around 10-fold lower. Chickens infected with the UL47-deletion mutant developed 
only moderate respiratory symptoms and recovered completely. Additionally, Helferich et al. 
ruled out that UL47 is relevant for the humoral immune response. Hence, possible protection 
potential of a mutant lacking the UL47 gene was investigated. Challenge experiments 
resulted in the absence of marked clinical symptoms and no lesions within the trachea were 
found by histopathology. Moreover, no ILT virus could be re-isolated. Nevertheless, in 
tracheal swabs ILTV DNA was detectable by PCR. 
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2.1.4 Virion packaging signal (VPS) 
In a study of Schlegel and Blaho 2009 [30], an incidentally generated in-frame fusion of the 
green fluorescent protein (GFP) to the carboxy-terminal end of the abundant tegument 
protein VP22 occurred and resulted in the packaging of GFP into HSV-1 particles. GFP alone 
was not incorporated into virions. This let to the hypothesis of the existence of a virion 
packaging signal at the C-terminal end of VP22. Finally, they identified a domain within the 
last 15 amino acids of VP22, which contains a motif of six consecutive amino acids: 
ARSASR. This sequence is conserved among HSV-1, herpes simplex virus type 2 (HSV-2) 
and varicella zoster virus (VZV).  
 
The alignment of HSV-1 VP22 with various ILTV sequences revealed a similar amino acid 
motif at the carboxy-terminal end of UL47 (Fig. 4. ARSASR in HSV-1 and AVSARR in 
ILTV). This let us to the assumption that this domain might be responsible for packaging of 
UL47 into ILTV particles. Besides this similarity within the C-terminal sequence, no major 
sequence homologies are apparent. Furthermore, it should be noted that ILTV UL47 consists 
of 623 amino acids in total compared to 301 amino acids for HSV-1 VP22 (deduced from 
GenBank DNA sequences NC_006623 and NC_001806). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 12 
Alignment of HSV-1 VP22 and ILTV UL47 
CLUSTAL multiple sequence alignment by MUSCLE (3.8) 
 
HSV-1 MTSRRSVKSGP-------------REVPRDEYED--LYYTPSSGMASPDSPPDTSRRGAL 
ILTV MTLPHRLTKRPFARRFCSVFVIQYSETKLDRYNKTMLLFRPDSTMRHSGG--DANHRG-I 
      **  . :.. *              *.  * *:.  * : *.* *  ...  *:..** : 
 
HSV-1 QTRSRQRGEVRFVQYDESDYALYGGSSSEDDEHPEVPRTRRPVSGAVLSGPG-------- 
ILTV RPRRKSIGAFSAREKTGKRNALTESSSSPADMLDPFSTDKEFGGKWTVDGPADITAEVLS 
      ..* .. * .   :   .  **  .***  *    ..  .   .  .:.**.         
 
HSV-1 ------------------------PARAPPPPAGSGGAG-------RTPTTAPRAPRTQR 
ILTV QAWDVLQLVKHEDAEEERVTYESKPTPIQPFNAWPDGPSWNAQDFTRAPIVYPSAEVLDA 
                              *:   *  * ..*..       *:* . * *   :  
 
HSV-1 VATKAPA-----APAAETTRGRKSAQPESAA--LPDA----------------------P 
ILTV EALKVGAFVSRVLQCVPFTRSKKSVTVRDAQSFLGDSFWRIMQNVYTVVLRQHITRLRHP 
       * *. *       ..  **..**.   .*   * *:                      * 
 
HSV-1 ASTAPTRSKTPA-QGLARKLHFS---------TAPPNPDAPWTPRVAGF----------- 
ILTV SSKSIVNCNDPLWYAYANQFHWRGMRVPSLKLASPPEENIQHGPMAAVFRNAGAGLFLWP 
      :*.: ...: *   . *.::*:          ::**: :  . * .* *            
 
HSV-1 ---------NKRVFCAAVGRLAAMHARMAAV--QLW----DMSR---------------- 
ILTV AMRAAFEERDKRLLRACLSSLDIMDAAVLASFPFYWRGVQDTSRFEPALGCLSEYFALVV 
               :**:: *.:. *  * * : *     *    * **                 
 
HSV-1 ------------------------------------PRTDEDLNELLG------------ 
ILTV LLAETVLATMFDHVLVFMRALADGNFDDYDETRYIDPVKNEYLNGAEGTLLRGIVASNTA 
                                          * .:* **   *             
 
HSV-1 --------------ITTIRVTVCE------------------------------------ 
ILTV LAVVCANTYSTIRKLPSVATSACNVAYRTETLKARRPGMSDIYRILQKEFFFYIAWLQRV 
                    :.:: .:.*:                                     
 
HSV-1 ---------------------------GKNLLQRANELVNP------------------- 
ILTV ATHANFCLNILKRSVDTGAPPFLFRASSEKRLQQLNKMLCPLLVPIQYEDFSKALGSELK 
                                 .:: **. *::: *                    
 
HSV-1 ------------------------------DVVQD---------------VDAATATRGR 
ILTV REKLETFVKAISSDRDPRGSLRFLISDHAREIIADGVRFKPVIDEPVRASVALSTTAAGK 
                                    ::: *               *  :*:: *. 
 
HSV-1 SAASRPTE-RPRAPARSASRPRRPVE- 
ILTV VKARRLTSVRAPVPGAGAVSARRKSEI 
        * * *. *. .*. .*  .**  * 
 
* = positions which have a single, fully conserved residue.  
: = conservation between groups of strongly similar properties 
. = conservation between groups of weakly similar properties  
Residue Style Property 
AVFPMILW STANDARD Small (small + hydrophobic) 
DE BOLD Acidic 
RK UNDERLINED Basic 
STYHCNGQ DOUBLE UNDERLINED Hydroxyl + sulfhydryl amine + G 
 
HSV-1  287   RAPARSASRPRRPVE  301 
ILTV  611  GAGAVSARRKSEI       623 
 
 
 
FIG. 4. Alignment of HSV-1 VP22 and ILTV UL47. 
The rectangle marks the similar consecutive motif of six amino acids at the C-terminal end, 
ARSASR in HSV-1 or AVSARR in ILTV respectively. Identical amino acids are highlighted 
in grey.  
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2.2 Reporter virus 
Reporter viruses are widely used in research. Basically two types of reporter viruses are 
distinguished: 
 
- Viruses, which express a marker gene such as GFP or luciferase. Therefor the marker 
gene needs to be incorporated into the viral genome and thus will be expressed in 
infected cells. By measuring the resulting fluorescence or luminescence respectively, 
quantitative information about the infection can be obtained.  
 
- Viruses, which are tagged by fluorescent dyes (e.g. Cyanine or Phycoerythrin; Cy3, 
PE) or by one or more marker proteins (e.g. green or red fluorescent protein; GFP, 
RFP). The marker proteins are modified in a way that they get incorporated into viral 
particles. This allows monitoring of individual viruses and real-time tracking of 
ongoing infection steps like cell binding and virus entry. 
 
The few things known about the replication cycle of ILTV were mainly adapted from the 
knowledge about other alphaherpesviruses. To provide a tool for further investigations of 
ILTV-cell-interactions, the development of a reporter virus incorporating a fluorescent 
protein is useful and demanded. Aiming at a more detailed understanding of early steps of 
infection (virus attachment and entry), the second type of reporter virus was chosen in the 
herein presented work.  
 
 
 
2.3 The monomeric green fluorescent protein 
The monomeric variant of the Neon Green protein (mNG) is derived from Branchiostoma 
lanceolatum, a lancelet belonging to the order Amphioxiformes, subphylum 
Cephalochordata. Compared with most commonly used green and yellow fluorescent 
proteins, it has superior optical properties with a high quantum yield and extinction 
coefficient, resulting in the brightest monomeric green or yellow fluorescent protein yet 
described [31]. The performance of mNG as fluorescent probe in live-cell imaging has been 
successfully determined, what gives us the reason to choose mNG as fluorescent marker in 
our investigations. The pNCS-mNeonGreen plasmid delivers mNG for our study (Fig. 9, 
mNG is marked with a star). 
 
 
 
 
 
 
 
 
 14 
2.4 Stable cell lines generated with retroviral vectors 
Stable cell lines were established by transduction with retroviral vectors. Those were 
generated by transfecting producer cells with three plasmids: the packaging construct 
(pHit60), the envelope construct (pMD2.G) and the respective transfer vectors including the 
long terminal repeats (LTR’s) and the packaging signal ψ (Fig. 5). The retroviral vectors 
were used for transduction of leghorn male hepatoma cells (LMH) to achieve a stable 
insertion of the transfer vectors into the cellular genome. LMH cells are supposed to be the 
only permanent cell line, which enables replication of ILTV [32], [33], [34]. Subsequent 
selection for cells with inserted transfer vectors was achieved by antibiotic selection, since an 
antibiotic resistance gene was also delivered by the transfer vector (Fig. 10, marked with a 
star). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
gag pol env LTRLTR
ψ
gag pol poly	A
env
transgen [GFP]	 LTRLTR
ψ
P
P poly	A
X
pHit60
pMD2.G
1.
2.
3.
1. packaging construct 
2. envelope construct
3. transfer vector
tra
ns
fe
ct
io
n
transduction
FIG. 5. Schematic illustration of transfection and transduction experiments to obtain stable 
cell lines. 
Three plasmids were used to transfect suitable cell lines: packaging constructs pHit60, 
envelope constructs pMD2.G and the respective transfer vectors. Selection of cell lines was 
done by adding antibiotics, marked with “X”. 
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2.5 Aim of the study  
This project is focused on the generation of an ILT reporter virus with incorporated 
mNeonGreen-UL47 fusion protein, enabling live monitoring of ILTV in vitro. The tegument 
proteins are incorporated into virus particles due to a specific virion packaging signal (VPS). 
For HSV-1 VP22, this sequence was identified as six amino acids (ARSASR) at the C-
terminal domain. It is conserved among HSV-1, HSV-2, and VZV [30]. For ILTV UL47, 
such a sequence is not known yet. HSV-1 VP22 and ILTV UL47 only share 28.5% sequence 
homology. Furthermore, ILTV UL47 is about twice as big as HSV-1 VP22. Nevertheless, the 
carboxy-terminus of ILTV UL47 contains an amino acid sequence (AVSARR) pretty close to 
the identified packaging signal for HSV-1 (Fig. 4). 
 
To identify the ILTV UL47 VPS, different overlapping fragments of the UL47 gene were 
fused to the monomeric neon green protein (mNG). First, transient expression of the newly 
generated constructs was tested in LMH cells. Thereupon, stable cell lines were generated by 
transduction with retroviral transfer vectors and subsequent selection of the cells. The stable 
cell lines were used to produce an ILTV mutant virus that lacks the wild type (wt) UL47 
protein. It was supposed to incorporate the mNG fused to the putative VPS (Fig. 6).  
 
 
 
 
 
 
 
 
 
 
mNG-UL47	UL47	
FIG. 6. Model of ILT reporter virus with incorporated mNG-UL47 fusion proteins. 
In wild type ILTV, UL47 is an abundant tegument protein. When fused to mNG, this should 
also be widely distributed among the tegument. 
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3. Material and Methods 
3.1 Material 
3.1.1 Chemical reagents 
Reagent Origin 
Cloning experiments  
1 Kb Plus DNA Ladder 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. 10787-018 
5x Fusion HF Buffer 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. F518L 
10x DNA loading buffer 1.5 g Ficoll 400, 2 ml EDTA, 0.5 ml bromophenol blue, ad 7 ml H2O  
Adenosine triphosphate (dATP) 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. R0141 
Agarose, LE, Analytical Grade 
Promega Corporation / Promega AG, Dübendorf CH 
www.promega.com Cat. No. V3125 
Buffer O 
Thermo Fisher Scientific - France, Illkirch FR 
www.thermofisher.com Cat. No. BO5 
dNTPs 
QIAGEN AG, Hombrechtikon CH 
https://www.qiagen.com Cat. No. 201900 
Double-distilled water (ddH2O) 
Prepared in laboratory at institute of veterinary bacteriology 
University of Zurich, Switzerland 
Ethidium bromide solution (EtBr) 1% 
Carl Roth GmbH + Co. KG / Roth AG, Arlesheim CH 
www.carlroth.com / www.carlroth.ch Cat. No. 2218.1 
LB-agar plates (incl. 100 µg/ ml Ampicillin) 
Difco TM 
Becton Dickinson AG, Allschwil CH 
www.bdbiosciences.com Cat. No. 244520 
LB-Amp medium 5 ml LB broth, 5 µl Ampicillin 
LB Broth 
Becton Dickinson AG, Allschwil CH 
www.bdbiosciences.com Cat. No. 244620 
NEBuffer 3.1 
New England Biolabs / Bioconcept, Allschwil CH 
www.neb.com / www.bioconcept.ch  Cat. No. B7203S 
S.O.C. Medium 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. 15544-034 
TAE Buffer 0.4 M Tris, 0.1 M Na2EDTA pH 8.0, 0.2 M glacial acetic acid 
Transfection  
DMEM Dulbecco’s Modified Eagle Medium 
Sigma Aldrich Chemie GmbH, Buchs CH 
www.sigmaaldrich.com Cat. No. D6429 
FBS  Fetal Bovine Serum 10% 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. 10270106 
Opti-MEM® 
Reduced Serum 
Medium, no phenol 
red 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. 11058021 
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Penicillin-
Streptomycin Antibiotic agent 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. 15140148 
TransIT®-2020 Transfection reagent 
Mirus Bio LLC / LabForce AG, Muttenz CH 
https://www.mirusbio.com Cat. No. MIR 5400 
Trypan Blue solution Staining, detection of damaged/dead cells 
Sigma Aldrich Chemie GmbH, Buchs CH 
www.sigmaaldrich.com Cat. No. T8154 
Trypsin-EDTA 
solution 
Adherent cells 
separation 
Sigma Aldrich Chemie GmbH, Buchs CH 
www.sigmaaldrich.com Cat. No. T3924 
Transduction  
Dulbecco’s 
phosphate buffered 
saline (PBS) 
Balanced salt solution 
Sigma Aldrich Chemie GmbH, Buchs CH 
www.sigmaaldrich.com Cat. No. D8537 
G418 
Aminoglycoside AB 
(Geneticin-
Disulphate) 
Carl Roth GmbH + Co. KG / Roth AG, Arlesheim CH 
www.carlroth.com / www.carlroth.ch Cat. No. CP11.2 
Paraformaldehyde Cell fixation 
Carl Roth GmbH + Co. KG / Roth AG, Arlesheim CH 
www.carlroth.com / www.carlroth.ch Cat. No. 0335.1 
Polybrene Cationic polymer 
Sigma Aldrich Chemie GmbH, Buchs CH 
www.sigmaaldrich.com Cat. No. 107689 
Waymouth’s 
medium Cell culture medium 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. 31220-023 
Western blot 
6x Loading buffer (Lämmli) 
5 ml glycerine 87%, 2.5 ml β-mercaptoethanol, 15 ml sodium 
dodecyl sulphate 10%, 6.25 ml upper Tris, 12.5 mg bromphenol 
blue, ad 50 ml H2O  
BenchMarkTM Pre-Stained Protein Ladder 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. 10748010 
Blocking buffer 5% non-fat dry milk powder in TBS 1x 
Blotting buffer 100 ml chamber buffer, 150 ml methanol, ad 1000 ml H2O 
Chamber buffer 10x 30.275 g Tris-hydroxy-methyl-aminomethan, 144.134 g glycine, ad 1000 ml H2O 
Enhanced chemiluminescence (ECL) reagent  
1 ml Solution A, 0.3 µl H2O2 35%, 100 µl Solution B 
Solution A: 500 ml 0.1 M Tris-HCl (pH 8.6), 125 mg Luminol 
Solution B: 11 mg para-hydroxycoumarin acid, 10 ml dimethyl 
sulfoxide 
Lower Tris 91 g Tris, 400 ml H2O, HCl until pH 8.8, 20 ml SDS 10%, ad 250 ml H2O 
Separation gel (10%) 
10 ml H2O, 8.4 ml 30% acrylamide/Bis solution, 6.5 ml lower 
Tris pH 8.8, 15 µl tetramethylenethylendiamine, 200 µl 
ammonium persulfate 10% 
Stacking gel 
6.5 ml H2O, 1 ml 30% acrylamide/Bis solution, 2.5 ml upper 
Tris pH 6.8, 20 µl tetramethylenethylendiamine, 40 µl 
ammonium persulfate 10% 
Rapilait, non-fat dry milk powder 
Migros, LeShop 
www.leshop.ch EAN 7610200017598 
RIPA Lysis Buffer 
Santa Cruz Biotechnology, Heidelberg DE 
www.scbt.com Cat. No. sc-14948 
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TBS 19.8 mM Tris, 500 mM NaCl 
TTBS TBS 1x, 0.05% Tween 20 
Upper Tris 15.25 g Tris, 400 ml H2O, HCl until pH 6.8, 10 ml SDS 10%, ad 250 ml H2O 
Infection experiment  
Goat serum 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. 16210064 
Poly-L-lysine solution 
Sigma-Aldrich Chemie GmbH, Buchs CH 
www.sigmaaldrich.com  Cat. No. A-005-C 
 
 
 
 
3.1.2 Enzymes and buffers 
Enzyme Buffer Origin 
Restriction Enzymes 
BamHI NEBuffer 3.1 
New England Biolabs / Bioconcept, Allschwil CH 
www.neb.com / www.bioconcept.ch  Cat. No. R0136S 
BglII NEBuffer 3.1 
New England Biolabs / Bioconcept, Allschwil CH 
www.neb.com / www.bioconcept.ch Cat. No. R0144S 
Eco47III (Afel) Buffer O 
Thermo Fisher Scientific - France, Illkirch FR 
www.thermofisher.com Cat. No. ER0321 
NotI NEBuffer 3.1 
New England Biolabs / Bioconcept, Allschwil CH 
www.neb.com / www.bioconcept.ch Cat. No. R0189S 
DNA Polymerase 
Phusion HighFidelity 
DNA Polymerase Phusion HF  
Thermo Fisher Scientific - France, Illkirch FR 
www.thermofisher.com Cat. No. F530S 
Ligase 
T4 DNA Ligase NEBuffer 3.1 
New England Biolabs / Bioconcept, Allschwil CH 
www.neb.com / www.bioconcept.ch Cat. No. M0202S 
 
 
 
 
TABLE 1. Chemical reagents and their origin. 
Chemical reagents used for cloning of mNG-UL47 fusion fragments, transfection of 293T 
cells, transduction of LMH cells, Western blot analysis of UL47 fusion proteins as well as 
infection of LMH cells and generation of ILT reporter viruses. 
 
TABLE 2. Enzymes and buffers and their origin. 
Enzymes and buffers used for cloning of mNG-UL47 fusion fragments. 
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3.1.3 Plasmids and DNA 
Plasmid, DNA Features Origin 
Cloning experiments  
ILTV DNA Isolated from the virulent A-489 ILTV strain 
Federal Research Institute for Animal Health’, Friedrich-
Loeffler-Institut, Greifswald-Insel Riems, Germany 
pLEGFP-N1 Retroviral vector 
Becton Dickinson AG, Allschwil CH 
www.bdbiosciences.com  Cat. No. 6059-1 
pNCS-mNeonGreen 
(pNCS-mNG) 
Bacterial expression 
vector. Constitutively 
expressing 6xHis-tagged 
mNeonGreen in E. coli 
Allele Biotechnology, San Diego, CA, USA 
www.allelebiotech.com Cat. No. ABP-FP-MNEONSB 
Transfection  
pHit60 
packaging construct, 
derived from murine 
leukemia virus, encoding 
for gag and pol 
Soneoka et al., 1995 [35] 
pMD2.G 
envelope construct, 
derived from Vesicular 
Stomatitis Virus 
A gift from Didier Trono (unpublished) 
pL-mNG-N1 Transfer vector In the presented work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 3. Plasmids and DNA and their origin. 
Plasmids an DNA used for cloning of mNG-UL47 fusion fragments and for transfection of 
293T cells. 
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3.1.4 Primers 
Origin:  Microsynth AG, Balgach CH 
  www.microsynth.ch 
 
Name Nucleotide sequence Length 
BglII_mNG(+) GTACTAGATCTCCACCATGGTGAGCAAGGGCGAGGAGGATAAC 43mer 
mNG(-) ACTACCACCACCACCCTTGTACAGCTCGTCCATGCCCATCAC 42mer 
mNG_Not(-) GGAAGCGGCCGCTCCTCACTTGTACAGCTCGTCCATGCCCATCAC 45mer 
1UL47_1-75(+) GGTGGTGGTGGTAGTACCTTGCCCCATCGATTAACGAAAAG 41mer 
1UL47_1-75_Not(-) GGAAGCGGCCGCTCCTCATTTTCCAGTCTTTTCGCGCGCGCTAAAC 46mer 
2UL47_60-155(+) GGTGGTGGTGGTAGTAGGCGGAAATCTATTGGAGCGTTTAGC 42mer 
2UL47_60-155_Not(-) GGAAGCGGCCGCTCCTCAACTCGGCCCGTCCGGCCAGGCATTGAAC 46mer 
3UL47_140-245(+) GGTGGTGGTGGTAGTAAACCGACCCCGATACAGCCGTTCAATG 43mer 
3UL47_140-245_Not(-) GGAAGCGGCCGCTCCTCAGTTGCAGTTAACAATGCTTTTGCTGG 44mer 
4UL47_230-335(+) GGTGGTGGTGGTAGTATAACTCGACTCAGGCACCCTTCCAGC 42mer 
4UL47_230-335_Not(-) GGAAGCGGCCGCTCCTCAGACGCCGCGCCAGTAAAATGGAAACGAC 46mer 
5UL47_321-430(+) GGTGGTGGTGGTAGTGACGCAGCCGTCCTCGCGTCGTTTCCA 42mer 
5UL47_321-430_Not(-) GGAAGCGGCCGCTCCTCATTTTCTTATCGTCGAATAGGTGTTTGC 45mer 
6UL47_380-470(+) GGTGGTGGTGGTAGTGGCAATTTCGATGACTATGACGAAACTAG 46mer 
6UL47_380-470_Not(-) GGAAGCGGCCGCTCCTCAAATGTAAAAGAAAAACTCTTTTTGTAA 45mer 
7UL47_456-555(+) GGTGGTGGTGGTAGTAGCGACATATACCGGATATTACAAAAAGAG 45mer 
7UL47_456-555_Not(-) GGAAGCGGCCGCTCCTCACCCCCTCGGGTCCCTGTCGCTGGAAATAG 47mer 
8UL47_540-622(+) GGTGGTGGTGGTAGTTTAGAGACATTCGTTAAAGCTATTTCC 42mer 
8UL47_540-622_Not(-) GGAAGCGGCCGCTCCTCATATTTCCGATTTCCGGCGCGCGGAAAC 46mer 
9BglII_mNG(+) GTACTAGATCTCCACCATGGTGAGCAAGGGCGAGGAGGATAACATGGCCTCTCTCCCAGCGACACATGAGTTA 73mer 
9UL47_610-622_Not(-) GGAAGCGGCCGCTCATATTTCCGATTTCCGGCGCGCGGAAACGGCGCCTGCGCCCGGCTTGTACAGCTCGTCCATG 76mer 
CMV-for CGCAAATGGGCGGTAGGCGTG 21mer 
 
TABLE 4. Oligonucleotides used for cloning of mNG-UL47 fusion fragments.  
Highlighted in grey: NotI cleavage site, double underlined: BglII cleavage site, underlined: 
(GGGGS)-linker, italic and highlighted in grey: mNG, bold: start codon.  
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3.1.5 Extraction and purification kits 
Kit Application Origin 
NucleoSpin® Gel and PCR Clean-up Gel Extraction 
Macherey-Nagel, Oensingen CH 
http://www.mn-net.com Cat. No. 740609.250 
NucleoSpin® Gel and PCR Clean-up  PCR Clean-up 
Macherey-Nagel, Oensingen CH 
http://www.mn-net.com Cat. No. 740609.250 
QIAprep® Spin Miniprep Kit (250) Plasmid Miniprep 
QIAGEN AG, Hombrechtikon CH 
https://www.qiagen.com Cat. No. 27106 
 
 
 
3.1.6 Bacteria strains 
Bacteria strain Origin 
Escherichia coli TOP 10 F’ 
Thermo Fisher Scientific - France, Illkirch FR 
www.thermofisher.com Cat. No. C303003 
Escherichia coli XL-10 gold 
Agilent Technologies, Basel CH 
www.agilent.com Cat. No. 200314 
 
 
 
3.1.7 Cells 
Cells Features Origin 
Transfection  
293T   
Human primary embryonic 
kidney cells, highly 
transfectable, Geneticin 
resistant 
Leibniz-Institut DSMZ-Deutsche Sammlung von 
Mikroorganismen und Zellkulturen GmbH, Braunschweig 
DE 
www.dsmz.de Cat. No. ACC 635 
Transduction and infection 
Leghorn Male 
Hepatoma (LMH) 
Chicken Liver Hepatocellular 
carcinoma cell line, epithelial 
CLS Cell Lines Service GmbH, Eppelheim DE 
www.clsgmbh.de Cat. No. 601411 
 
 
TABLE 5. Extraction and purification kits and their origin. 
Extraction and purification kits used for cloning of mNG-UL47 fusion fragments. 
 
TABLE 6. Escherichia coli strains and their origin. 
Escherichia coli strains used for cloning of mNG-UL47 fusion fragments. 
 
TABLE 7. Cultured cell lines and their origin. 
Cells used for transfection or transduction experiments as well as for infection and generation 
of ILT reporter viruses. 
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3.1.8 Antibodies 
Antibody Origin 
Western blot 
1s
t  A
nt
ib
od
y 
 
rab-α-UL47 Helferich et al., 2007 [36] 
m-α-GFP 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. MA5-15256 
2n
d  A
nt
ib
od
y goat α-rab-HRP 
Cell Signaling Technology / Bioconcept, Allschwil CH 
www.cellsignal.com / www.bioconcept.ch Cat. No. 7074 
goat α-mouse-HRP 
Santa Cruz Biotechnology, Heidelberg DE 
www.scbt.com Cat. No. sc-2005 
Infection experiment 
goat α-mouse Alexa Fluor 594 
Thermo Fisher Scientific 
www.thermofisher.com Cat. No. A-11005  
 
 
 
3.1.9 Virus 
Virus Origin 
Virulent A-489 ILTV strain Federal Research Institute for Animal Health’, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany 
 
 
 
 
 
 
 
 
 
TABLE 8. Antibodies and their origin. 
Antibodies used for Western blot analysis and infection experiment. 
 
TABLE 9. Virus and its origin. 
ILT virus strain used for infection of LMH cells and generation of reporter viruses. 
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3.2 Methods 
3.2.1 Cloning of the mNG-UL47 fusion fragment transfer vectors 
3.2.1.1 Amplification and fusion of mNeonGreen and UL47 fragments 
In a first polymerase chain reaction (PCR), PCR 1, nine fragments of the UL47 gene were 
amplified (Fig. 7 PCR 1 A, Fig. 8) according to the protocol listed in table 10. Each amplicon 
is a particular part of the UL47 gene between 255 bp and 363 bp in length. In parallel, the 
mNG gene sequence was amplified (Fig. 7 PCR 1 B, Table 10 amplicon A). The overlapping 
oligonucleotides, listed in table 4, allowed the fusion of the respective UL47 fragment and 
the amplified mNG in PCR 2 due to complementarity of primer overhangs. One UL47 
fragment (UL47_610-622, amplicon 9) consists only of the last twelve C-terminal 
nucleotides of the entire UL47 gene. This sequence was already included within the primer 
sequence and thus directly fused to mNG. As template for the different UL47 fragments, high 
quality purified ILTV DNA was used. pNCS-mNG (Fig. 9) delivered the mNG gene 
sequence and was therefore used as template for amplicon A. 
 
In addition, mNG was amplified separately, for direct insertion into the expression vector 
(Fig. 7 PCR 1 B, Table 10 amplicon NG) to serve as mNG expression control in further 
experiments. 
A B 
FIG. 7. Scheme of the fusion PCR.  
PCR 1 illustrates the annealing of the primers at the particular fragment of UL47 (A) and at 
the mNG gene sequence respectively (B). The primers contain overlapping parts to enable 
fusion of the two fragments. PCR 2 shows the fusion of the UL47 fragments with the mNG 
gene resulting in mNG-UL47 fusion fragments. 
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FIG. 8. Scheme of the UL47 fragments 1 to 9, fused to mNG.  
Schematic overview of the nine fusion constructs and the pL-mNG-N1 as control for mNG 
expression. The amplified parts of UL47 are indicated in the name and the length is shown 
proportionally.  
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 4 5 6 
Template ILTV DNA ILTV DNA ILTV DNA 
(+) primer 4UL47_230-335(+) 5UL47_321-430(+) 6UL47_380-470(+) 
(-) primer 4UL47_230-335_Not(-) 5UL47_321-430_Not(-) 6UL47_380-470_Not(-) 
 
 
 7 8 9 
Template ILTV DNA ILTV DNA ILTV DNA 
(+) primer 7UL47_456-555(+) 8UL47_540-622(+) 9BglII_mNG(+) 
(-) primer 7UL47_456-555_Not(-) 8UL47_540-622_Not(-) 9UL47_610-622_Not(-) 
 
 
 NG A 
Template pNCS-mNG pNCS-mNG 
(+) primer BglII_mNG(+) BglII_mNG(+) 
(-) primer mNG_Not(-) mNG(-) 
 
 
 
 
 
 
 
 
 
 1 2 3 
Template ILTV DNA ILTV DNA ILTV DNA 
(+) primer 1UL47_1-75(+) 2UL47_60-155(+) 3UL47_140-245(+) 
(-) primer 1UL47_1-75_Not(-) 2UL47_60-155_Not(-) 3UL47_140-245_Not(-) 
TABLE 10. Templates and primers used for PCR 1. Amplification of UL47 fragments, 
amplicons A and NG. 
Amplicons 1 to 9 represent the nine fragments of the UL47 gene which are supposed to get 
fused to the mNG gene in a further PCR step. Amplicon NG is generated to serve as control 
for mNG expression, whereas amplicon A was used for fusion to the respective UL47 
fragments in PCR 2. 
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Reaction mixtures for PCR 1 were pipetted according to following protocol: 
 
 50 ng template 
 10 µl 5x Phusion HF Buffer 
 1 µl dNTP (10 mM) 
 2 µl Primer (+) (10 mM) 
 2 µl Primer (-) (10 mM) 
 0.5 µl Phusion DNA polymerase 
 add H2O to total volume of 50 µl 
 
 
For all reactions of PCR 1, identical thermocycling conditions were applied (Table 11 A). For 
fragment 9, the annealing temperature was modified by alteration to 44°C for 30 s (marked 
bold in Table 11 B). The thermocycling was performed in a 2720 thermal cycler (Applied 
Biosystems, Foster City, CA, USA). 
 
Each amplicon was verified by electrophoresis on a 1% agarose gel supplemented with 
0.02% ethidium bromide (EtBr) in TAE buffer. The electrophoresis was run for 90 to 
120 min with 100 V DC (direct current). As reference the 1 kb Plus DNA Ladder was used. 
The bands were visualized and photographed by using the AlphaImagerTM Gel Imaging 
System. 
 
 
A)          B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98°C 1’  
98°C 0.5’ 
25 x 46°C 0.5’ 
72°C 0.5’ 
72°C 5’  
4°C ∞  
98°C 1’  
98°C 0.5’ 
25 x 44°C 0.5’ 
72°C 0.5’ 
72°C 5’  
4°C ∞  
TABLE 11. Thermocycling conditions PCR 1. 
Thermocycling conditions for the amplification of UL47 fragments 1 to 8, amplicon A and NG 
(A) as well as for UL47 fragment 9 (B). The modification is highlighted in bold. 
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In a second PCR mNG (amplicon A) was fused to the respective UL47 fragment (amplicon 1 
- 8) (Fig. 7 PCR 2, Fig. 8) according to the protocol listed in table 12. The UL47 fragment 9 
sequence (UL47-610_622) is included within the primer and was already fused to mNG in 
PCR 1. Therefore, no further PCR step was necessary for this particular fragment. 
 
 
 
 
 
 
FIG. 9. Map of pNCS-mNeonGreen plasmid, Allele Biotechnology, San Diego, CA, USA. 
The plasmid pNCS-mNeonGreen was used as template for the amplification of both mNG 
fragments (amplicon A, amplicon NG). mNeonGreen is marked with a star. 
 
 28 
 A1 A2 A3 
Templates 
A A A 
1 2 3 
(+) primer BglII_mNG(+) BglII_mNG(+) BglII_mNG(+) 
(-) primer 1UL47_1-75_Not(-) 2UL47_60-155_Not(-) 3UL47_140-245_Not(-) 
 
 
 A4 A5 A6 
Templates 
A A A 
4 5 6 
(+) primer BglII_mNG(+) BglII_mNG(+) BglII_mNG(+) 
(-) primer 4UL47_230-335_Not(-) 5UL47_321-430_Not(-) 6UL47_380-470_Not(-) 
 
 
 A7 A8 
Templates 
A A 
7 8 
(+) primer BglII_mNG(+) BglII_mNG(+) 
(-) primer 7UL47_456-555_Not(-) 8UL47_540-622_Not(-) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 12. Templates and primers used for PCR 2. Amplification of mNG-UL47 fusion 
fragments A1 to A8. 
mNG amplified in PCR 1 (amplicon A) and the respective UL47 fragments (amplicon 1-8) 
were used to generate mNG-UL47 fusion fragments.  
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Reaction mixtures for PCR 2 were pipetted according to following protocol: 
 
 50 ng amplicon A 
 other templates as follows: 
  
 
10 µl 5x Phusion HF Buffer 
 1 µl dNTP (10 mM) 
 2 µl Primer (+) (10 mM) 
 2 µl Primer (-) (10 mM) 
 0.5 µl Phusion DNA polymerase 
 add H2O to total volume of 50 µl 
 
 
For all reactions of PCR 2, identical thermocycling conditions were applied (Table 13). The 
thermocycling was performed in a 2720 thermal cycler (Applied Biosystems, Foster City, 
CA, USA). 
 
98°C 1’  
98°C 0.5’ 
25 x 46°C 0.5’ 
72°C 1’ 
72°C 5’  
4°C ∞  
 
 
 
Each mNG-UL47 fusion fragment was verified by electrophoresis as described above. 
 
Amplicons were purified after the first and second PCR using the NucleoSpin® Gel and PCR 
Clean-up Kit (Table 5). Concentrations and purities were measured using the NanoDrop 
spectrophotometer (Witec AG, Littau, Switzerland. Data not shown). 
 
 
 
 
 
1: 17 ng 2: 22 ng 3: 24 ng 4: 24 ng 5: 25 ng 6: 21 ng 7: 23 ng 8: 20 ng 
TABLE 13. Thermocycling conditions PCR 2. 
Thermocycling conditions for the amplification of mNG-UL47 fusion fragments A1 to A8. 
 
 30 
3.2.1.2 Enzymatic restriction of mNG-UL47 fusion fragments and expression vector 
mNG-UL47 fusion fragments were enzymatically digested according to following protocol: 
 
 Whole eluate (40 µl or 90 µl respectively) 
 10 µl NEB buffer 3.1 
 1 µl BglII 
 1 µl NotI 
 
The reaction was incubated for 2 h at 37°C and subsequently purified using the NucleoSpin® 
Gel and PCR Clean-up Kit (Table 5). Concentrations and purities of these mNG-UL47 fusion 
fragments were measured using the NanoDrop spectrophotometer (Witec AG, Littau, 
Switzerland. Data not shown). 
 
 
The purified mNG-UL47 fusion fragments were inserted into expression vector pL-EGFP-N1 
(Fig. 10) by ligation. This vector was previously digested according to following protocol: 
 
 2 µg pL-EGFP-N1 
 10 µl NEB buffer 3.1 
 2 µl NotI 
 1 µl BglII 
 add H2O to total volume of 100 µl 
 
The mixture was incubated for 2 h at 37°C and subsequently verified by electrophoresis as 
described in chapter 3.2.1.1. The band with the specific size of the desired fragment was 
excised from the agarose gel, extracted and purified. The obtained concentration was 
measured as described above. 
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3.2.1.3 Ligation 
The ligation reaction using a molar ratio of 1:3 (insert:vector) was prepared corresponding to 
table 14. The retroviral vector pL-EGFP-N1 served as expression vector, inserts were the 
various mNG-UL47 fusion fragments and mNeonGreen only. 10 mM dATP was 
supplemented. Reactions were incubated over night at 16°C or for 10 min at 22°C. To 
inactivate the ligation complexes, the temperature was raised to 65°C for 15 min, followed by 
cooling down to room temperature (RT). 0.5 µl BamHI was pipetted to each reaction which 
was subsequently incubated for 45 min at 37°C. This step was included for linearization of 
circular, non-restricted vector plasmids. Two negative controls were prepared according to 
table 14 (Neg. Ctr. 1 and Neg. Ctr. 2). Both contained no inserts (control for unspecific 
ligation of the restricted vector) and Ctr. 2 in addition was lacking the T4 ligase (control for 
uncut vector). 
 
 
 
FIG. 10. Map of pL-EGFP-N1 plasmid, BD Biosciences Clontech, Protocol PT3233-5, 
Version PR29959.  
The retroviral vector pLEGFP-N1 serves as expression vector. It was digested using NotI and 
BglII resulting in the excision of EGFP. It carries two antibiotic resistant genes, Neor and 
Ampr, whereas the essential one for selection of eukaryotic cells is Neor, which is marked with 
a star. 
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 Neg. Ctr. 1 Neg. Ctr. 2 pL-mNG-N1 pL-mNG-UL47 _1-75 
Vector DNA 30 ng 30 ng 30 ng 30 ng 
Insert DNA --- --- 10 ng 10 ng 
NEB buffer 3.1 1 µl 1 µl 1 µl 1 µl 
dATP 1 µl 1 µl 1 µl 1 µl 
T4 ligase 0.5 µl --- 0.5 µl 0.5 µl 
Add H2O to a 
total volume 10 µl 10 µl 10 µl 10 µl 
 
 
 pL-mNG-UL47 _60-155 
pL-mNG-UL47 
_140-245 
pL-mNG-UL47 
_230-335 
pL-mNG-UL47 
_321-430 
Vector DNA 30 ng 30 ng 30 ng 30 ng 
Insert DNA 10 ng 5 ng 5 ng 5 ng 
NEB buffer 3.1 1 µl 1 µl 1 µl 1 µl 
dATP 1 µl 1 µl 1 µl 1 µl 
T4 ligase 0.5 µl 0.5 µl 0.5 µl 0.5 µl 
Add H2O to a 
total volume 10 µl 10 µl 10 µl 10 µl 
 
 
 pL-mNG-UL47 _380-470 
pL-mNG-UL47 
_456-555 
pL-mNG-UL47 
_540-622 
pL-mNG-UL47 
_610-622 
Vector DNA 30 ng 30 ng 30 ng 30 ng 
Insert DNA 5 ng 5 ng 5 ng 5 ng 
NEB buffer 3.1 1 µl 1 µl 1 µl 1 µl 
dATP 1 µl 1 µl 1 µl 1 µl 
T4 ligase 0.5 µl 0.5 µl 0.5 µl 0.5 µl 
Add H2O to a 
total volume 10 µl 10 µl 10 µl 10 µl 
 
 
 
 
 
 
TABLE 14. Mixtures of ligation reactions using a 1:3 molar ratio.  
Two negative controls (Neg. Ctr. 1 and Neg. Ctr. 2) were included. 
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3.2.1.4 Transformation of chemical competent E. coli and purification of plasmid DNA 
Escherichia coli TOP 10 F’ and Escherichia coli XL-10 gold (Table 6) were used for 
transformation of ligated vectors. Prepared aliquots of 50 µl were thawed on ice. 5 µl of the 
ligation reaction was added and incubated on ice for 30 min. The bacteria were heatshocked 
for 30 seconds in a 42°C water bath and placed back on ice. 250 µl S.O.C medium was 
pipetted into each vial followed by horizontally shaking with 200 rpm at 37°C for 1 h. 
Subsequently, the entire content of each vial was plated onto LB-agar-plates which were 
supplemented with ampicillin and incubated over night at 37°C. 
The following day, the grown bacteria colonies were counted and five colonies of each LB-
agar-plate were collected for plasmid isolation using the QIAprep® Spin Miniprep Kit (250) 
(Table 5). 
 
 
 
3.2.1.5 Control restriction analysis 
The digestions of newly generated plasmids harbouring the mNG-UL47 fusion fragments 
were done according to following protocol: 
 
 500 ng DNA 
 1 µl Buffer 0 
 0.5 µl Eco47III 
 add H2O to total volume of 10 µl 
 
The reaction mixture was incubated for 1 h at 37°C and subsequently verified by 
electrophoresis as described in chapter 3.2.1.1. 
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3.2.2 Transfection 
3.2.2.1 Transfection of 293T cells 
293T cells were cultured in DMEM (Dulbecco’s modified eagle medium) supplemented with 
9% fetal bovine serum (FBS) and Penicillin-Streptomycin (P/S) (100 U/ml penicillin / 
0.1 mg/ml streptomycin) to an approximately 90% confluent cell layer in a 10 cm dish. After 
detaching and resuspending the cells in 7.5 ml DMEM, cells were counted using a Neubauer 
improved cell counting chamber and adjusted to a final concentration of 2 x 105 cells per ml. 
Cells were seeded in a 12-well plate, 1 ml per well. 24 h after seeding, the 293T cells were 
transfected by lipofection using TransIT-2020 as transfection reagent. For generation of 
retroviral vectors, the packaging construct pHit60, the envelope construct pMD2.G and one 
of the newly generated mNG-UL47 fusion fragment transfer vectors were co-transfected into 
293T cells using the following mixture: 
  
 100 µl OptiMEM 
 0.6 µg transfer vector 
 0.4 µg pHit60 
 0.2 µg pMD2.G 
 3 µl TransIT-2020 
 
As negative control, 293T cells were transfected with OptiMEM and TransIT-2020 only. The 
transfection mixture was incubated for 20 min at RT. The medium was replaced with 
1 ml DMEM containing neither FBS nor antibiotics and the transfection mix was gently and 
dropwise added to the cells in the 12-well plate. Following incubation at 38°C and 5% CO2 
for 4 h, 11 µl P/S were pipetted to each well. After approximately 24 h of incubation at 38°C 
and 5% CO2, all wells were monitored for fluorescence. 
 
 
 
3.2.2.2 Monitoring immunofluorescence of 293T cells 
About 24 h and 48 h post-transfection, the immunofluorescence of transfected 293T cells was 
monitored with a Zeiss light microscope (Axiovert 25) and compared to the negative control. 
The fluorescence intensity and quantity within each well was assessed subjectively by a 
rating scheme with values negative (-), low (+), moderate (++) or high (+++) at 48 h post-
transfection. 
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3.2.3 Transduction 
3.2.3.1 Transduction of LMH cells 
7 x 105 LMH cells per well were seeded in 6-well plates and were cultivated in 2 ml 
Waymouth’s medium supplemented with 9% FBS and P/S (100 U/ml penicillin / 0.1 mg/ml 
streptomycin). The next day, retroviral vector-containing supernatant (SN) of transfected 
293T cells was harvested and filtered through a 0.45 µm PES-membrane filter. 1 ml of the 
yield was directly added to the respective LMH cells. To increase transduction efficiency, 
Polybrene was added in a final concentration of 1 ng/ml to each well. Polybrene is a cationic 
polymer which is supposed to enhance retrovirus-mediated gene transfer [37], [38]. As 
retroviruses can only infect/transduce growing cells [39], [40] and Polybrene has toxic effects 
on cells depending on the time of exposure and concentration [41], the appropriate amount 
and incubation time was determined in advance. The 6-well plates were centrifuged with 
2500 rpm for 30 min at RT, followed by incubation at 38°C and 5% CO2 for 5 h. Thereafter, 
LMH cells were washed carefully with 1 ml Dulbecco’s phosphate buffered saline (PBS) and 
the medium was replaced with Waymouth’s medium supplemented with 9% FBS and P/S 
(100 U/ml penicillin / 0.1 mg/ml streptomycin). After 24 h of incubation at 38°C and 5% 
CO2, all wells were monitored for fluorescence. 
 
 
 
3.2.3.2 Monitoring immunofluorescence of LMH cells 
A subset of cells was grown on cover slips. After fixation with 3% paraformaldehyde (PFA) 
and staining of the nuclei with DAPI, cells were monitored for expression and localization of 
the mNG-UL47 fusion proteins by using an Olympus IX81 inverted epifluorescence 
microscope. DIC and fluorescent images were taken at 60x magnification. 
 
 
 
3.2.3.3 Antibiotic selection 
Cells stably expressing the mNG-UL47 fusion proteins were selected by using G418 
(Geneticin), an aminoglycoside antibiotic. It inhibits the protein synthesis in prokaryotic and 
eukaryotic cells likewise. The resistance to G418 is conferred by the Neomycin resistant gene 
(Neor, Fig. 10) [42]. Due to the presence of Neor on the newly generated transfer vectors, 
cells, which express the UL47-mNG fusion proteins, are also supposed to express the 
Neomycin resistance gene and therefore be unsusceptible to antibiotic treatment with G418. 
 
 
 
 
 
 36 
3.2.4 Western blot 
3.2.4.1 Western blot of UL47 fusion proteins 
To demonstrate the incorporation and successful expression of the mNG-UL47 fusion 
fragments in 293T cells, Western blot analysis was performed. 
 
In a 25 cm2 cell culture flask 293T cells were cultured in DMEM supplemented with 9% FBS 
and and P/S (100 U/ml penicillin / 0.1 mg/ml streptomycin) to a density of approximately 
90%. After detaching and resuspending the cells in 7.5 ml DMEM, cells were counted using 
a Neubauer improved cell counting chamber and adjusted to a final concentration of 
2 x 105 cells per ml per well. Cells were seeded in a 12-well plate, 1 ml per well. 24 h after 
seeding, the 293T cells were transfected by lipofection using the TransIT-2020 transfection 
reagent according to following protocol: 
 
100 µl OptiMEM 
 1 µg DNA 
 3 µl TransIT-2020 
 
The transfection mixture was incubated for 20 min at RT. The medium was replaced with 
1 ml DMEM containing neither FBS nor antibiotics and the transfection mix was gently and 
dropwise added to the cells in the 12-well plate. Following incubation at 38°C and 5% CO2 
for 4 h, 11 µl P/S was pipetted to each well. After 24 h of incubation at 38°C and 5% CO2 the 
cells were washed with PBS. 1 ml PBS was added to each well and cells were scraped of and 
transferred to Eppendorf tubes. Subsequently, the cells were spun down with 10’000 rpm for 
10 min at RT and thereupon the pellets were lysed using RIPA lysis buffer. 
 
To determine the protein concentration, the Bradford Protein Assay method [43] was used. 
 
15 µg of obtained lysates were incubated at 95°C for 5 min together with Lämmli buffer and 
loaded onto a 10% SDS polyacrylamide gel. The gel ran 30 min with 50 V followed by 
100 V for 90 min according to standard SDS PAGE protocol in the Mini-PROTEAN® Tetra 
System (Bio-Rad). 
 
The blotting was performed with the Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell 
(Bio-Rad) with 20 V for 1 h. Before blotting, filter papers and nitrocellulose membranes were 
soaked in blotting buffer and thereafter assembled on the cathode plate together with the gel, 
carefully to avoid air bubbles. To prevent unspecific antibody binding, membranes were 
blocked for 1 h while shaking at RT using 5% milk powder in Tris-buffered saline (TBS). 
 
Nitrocellulose membranes were incubated with the primary antibody (rab-α-UL47, 1:10’000 
or m-α-GFP, 1:5’000 in 2.5% milk powder in TTBS) at 4°C shaking over night. The next 
day, nitrocellulose membranes were washed three times with TTBS for 5 min each at RT 
shaking. Incubation with the secondary antibody (goatα-rab-HRP or goat α-mouse-HRP, 
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1:1000 in 2.5% milk powder in TTBS) was done at RT for 1 h shaking and followed by a 
washing step with TTBS and two times washing with TBS for approximately 10 min each. 
For detection, the membranes were incubated with enhanced chemiluminescence (ECL) 
reagent for 2 min. Subsequently, they were exposed to Fuji Medical X-ray film 100 NIF with 
different exposure times, 1, 5 or 15 min. The films were developed using the Agfa Curix 60 
(Schenk AG, Hettlingen CH). 
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3.2.5 Infection of LMH cells and generation of ILT reporter viruses 
3.2.5.1 Generation of ILT reporter viruses and microscopic analysis 
Generated LMH cell lines with incorporated mNG-UL47 fusion fragments were cultured in 
10 cm dishes in Waymouth’s medium supplemented with 10% FBS at 38°C and 5% CO2. 
48 h after seeding, cells were infected with a mutant ILTV lacking the UL47 gene (ILTV-
ΔUL47). Incubation of infected cells lasts till a cytopathic effect was observed. Viral 
particles were collected, filtered through a 0.45 µm filter and subsequently concentrated by 
centrifugation for 1 h at 48’000x g (supernatant was discarded and particles were 
resuspended in 200 µl PBS). For microscopic analysis, glass coverslips (cs) were coated with 
0.01% Poly-L-lysine solution for 1 h at RT. The cs were washed twice with ddH2O. For 
binding, 100 µl of virus solution was added per cs and incubated for 1 h at RT. The virus 
solution was aspirated and cs were washed once with PBS. Viruses were fixated with 3% 
PFA. After blocking with 10% goat serum for 30 min at RT, cs were incubated with an 
antibody recognizing the ILTV glycoprotein J (gJ) (1:50 in 10% goat serum) for 1 h at RT. 
After washing three times with PBS, the cs were incubated with α-mouse-AlexaFluor 594 for 
1 h at RT in the dark. This was followed by washing twice with PBS and mounting of the cs 
onto microscope slides. Images were recorded with 100x magnification with the Zeiss 
Axiovert Observer Z1 microscope. The amount of fluorescence spots was subjectively rated 
by a rating scheme with values negative (-), low (+), moderate (++) or high (+++). 
 
FIG. 11. Scheme of the generation of ILT reporter viruses. 
LMH cells were infected with mutant ILTV that lacks the wild type UL47 protein. Subsequent 
propagation of reporter virus with incorporated mNG-UL47 fusion fragments. 
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4. Results 
4.1 Cloning of the mNG-UL47 fusion fragment transfer vectors 
Amplification and fusion of the respective UL47 fragments to mNG was successfully 
achieved. This was shown by gel electrophoresis as described in chapter 3.2.1.1 (Fig. 12, 13 
and Table 15, 16).  
  
The products of the first PCR appeared as distinct bands with the correct sizes (Table 15, Fig. 
12, A, B, C), while UL47 fragment 9 delivered a blurred band (Fig. 12, B). Hence, a modified 
cycler program with a decreased annealing temperature of 44°C (Table 11, B) was run for 
fragment 9, resulting in a more distinct signal (Fig. 12, D).  
 
 
 
 
Fragment 1 2 3 4 5 6 7 8 9 A NG 
Size (bp) 255 321 351 351 363 306 333 288 787 739 742 
 
 
 
TABLE 15. Expected band sizes of amplicons of PCR 1. 
UL47 fragments 1 to 8, mNeonGreen (A and NG). 
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FIG. 12. PCR 1. Amplification of nine UL47 fragments and two mNG gene sequences. 1% 
agarose gel. 
A: UL47 fragments 1-8, B: mNeonGreen (NG) for cloning the expression control plasmid and 
UL47 fragment 9 directly fused to mNG, C: mNeonGreen for fusion to the UL47 fragments 
(A), D Amplicon 9 repeated with a modified cycler program. 
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In the second PCR the UL47 fragments one to eight were fused to the mNG sequence. The 
fusion fragments appeared at the expected molecular weight size (Fig. 13, Table 16). Weak 
bands of smaller size were visible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fusion fragment A1 A2 A3 A4 A5 A6 A7 A8 
Size (bp) 979 1045 1075 1075 1087 1030 1057 1012 
 
 
 
 
 
 
 
 
 
 
 
FIG. 13. PCR 2. Amplification of fusion fragments A1 to A8. 
Fusion of UL47 fragments 1 – 8 to mNG. 1% agarose gel. 
 
TABLE 16. Expected band sizes of amplicons of PCR 2. 
UL47 fragments fused to mNG (A1 to A8). 
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Digestion of the expression vector with the respective restriction enzymes was controlled by 
electrophoresis as described in chapter 3.2.1.1 (Fig. 14 and Table 17). Bands corresponding 
to 6129 bp were excised from the agarose gel, extracted and purified. 
 
 
 
 
 
 
Expression vector Restriction enzyme Expected band sizes 
pL-EGFP-N1 NotI and BglII 762 bp 6129 bp 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 14. Restriction of pL-EGFP-N1 and isolation of the vector backbone. 1% agarose gel. 
The 100 µl restriction reaction was loaded into 5 pockets of the gel (lane 1 - 5). A. before and 
B. after excision of the vector backbone. 
 
TABLE 17. Restriction enzyme analysis of the vector backbone.  
Expected band size after restriction with NotI and BglII. 
 
 42 
mNG-UL47 fusion fragments were restricted using the same restriction enzymes (NotI and 
BglII). Upon purification, the fusion fragments were ligated into the vector backbone and the 
resulting plasmids were transformed into chemical competent Escherichia coli. The bacteria 
strains used for transformation and the number of colonies counted 24 h after transformation 
are listed in table 18. 
 
 
 
 
 
 
Five Escherichia coli colonies of each construct were picked and grown in LB-Amp medium. 
Plasmid DNA was isolated and correct cloning was verified by restriction enzyme analysis 
and subsequent DNA sequencing (Fig. 15). The restriction enzyme was equal for all 
generated constructs. Eight out of nine mNG-UL47 expression vectors showed the expected 
band sizes (Table 19). Restriction of mNG-UL47_610-622 did not result in correct band 
patterns in any analysed sample (Fig. 15). 
Construct Number of colonies Escherichia coli strain 
Negative control 1 0 / 0 TOP 10 F’ / XL-10 gold 
Negative control 2 0 / 5 TOP 10 F’ / XL-10 gold 
pL-mNG-N1 12 XL-10 gold 
pL-mNG-UL47_1-75 204 XL-10 gold 
pL-mNG-UL47_60-155 72 XL-10 gold 
pL-mNG-UL47_140-245 8 TOP 10 F’ 
pL-mNG-UL47_230-335 9 TOP 10 F’ 
pL-mNG-UL47_321-430 9 TOP 10 F’ 
pL-mNG-UL47_380-470 7 TOP 10 F’ 
pL-mNG-UL47_456-555 21 TOP 10 F’ 
pL-mNG-UL47_540-622 30 TOP 10 F’ 
pL-mNG-UL47_610-622 9 XL-10 gold 
TABLE 18. Amount of bacterial colonies. 
Colonies grown on LB-Amp-plates after transformation of the newly generated expression 
vectors into competent Escherichia coli colonies. 
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FIG. 15. Restriction enzyme analysis of newly generated UL47-mNG expression vectors. 
1% agarose gel.  
For each construct, five samples were analysed (lanes 1-5). Due to a lack of correct samples, 
additional five plasmids of pL-mNG-UL47_610-622 were analysed. Samples marked with an 
arrow were verified by sequencing and use for further investigation. 
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Construct Size (bp) 
pL-mNG-N1 549 1924 4352 
pL-mNG-UL47_1-75 549 1924 4589 
pL-mNG-UL47_60-155 549 1924 4655 
pL-mNG-UL47_140-245 549 1924 4685 
pL-mNG-UL47_230-335 549 1924 4685 
pL-mNG-UL47_321-430 549 1924 4697 
pL-mNG-UL47_380-470 549 1924 4640 
pL-mNG-UL47_456-555 549 1924 4667 
pL-mNG-UL47_540-622 549 1924 4622 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 19. Restriction enzyme analysis of generated constructs.  
Expected band size after restriction with Eco47III. 
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4.2 Transfection – Generation of retroviral vectors in 293T cells 
48 h after transfection, immunofluorescence was examined and resulted in the following 
observations: the negative control showed no fluorescence. Transfection of six out of nine 
mNG-UL47 expression constructs, namely pL-mNG-N1, pL-mNG-UL47_60-155, pL-mNG-
UL47_230-335, pL-mNG-UL47_321-430, pL-mNG-UL47_380-470 and pLmNG-
UL47_540-622 resulted in a high fluorescence intensity and quantity, as listed in table 20 A. 
Transfection of pL-mNG-UL47_1-75 and pL-mNG-UL47_456-555 showed moderate 
fluorescent intensity and quantity while transfection of pL-mNG-UL47_140-245 resulted in a 
few cells showing moderate fluorescent intensity (Table 20 A). Therefore, the transfection 
was repeated for those three constructs using double amounts of the respective transfer 
vectors. Fluorescence resulting from transfection of pL-mNG-UL47_1-75 remained 
unchanged. Upon transfection of pL-mNG-UL47_140-245 the amount of fluorescent cells 
increased slightly but with unchanged intensity, while transfection of pL-mNG-UL47_456-
555 showed slightly higher rates of both, fluorescence intensity and quantity (Table 20 B). 
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A 
 
B 
 
 
 
 
 
 
 
 
 
 
mNG-UL47 transfer vector Fluorescence intensity Fluorescence quantity 
Negative control - - 
pL-mNG-N1 +++ +++ 
pL-mNG-UL47_1-75 ++ ++ 
pL-mNG-UL47_60-155 +++ +++ 
pL-mNG-UL47_140-245 +/++ + 
pL-mNG-UL47_230-335 +++ +++ 
pL-mNG-UL47_321-430 +++ +++ 
pL-mNG-UL47_380-470 +++ +++ 
pL-mNG-UL47_456-555 ++ ++ 
pL-mNG-UL47_540-622 +++ +++ 
mNG-UL47 transfer vector Fluorescence intensity  Fluorescence quantity  
Negative control - - 
pL-mNG-UL47_1-75 ++ ++ 
pL-mNG-UL47_140-245 +/++ +/++ 
pL-mNG-UL47_456-555 ++/+++ ++/+++ 
TABLE 20. Results of transfection of fusion fragment transfer vectors subjectively rated with scores 
for fluorescence intensity and quantity 48 h post-transfection 
Rating scheme of the observed fluorescence: negative: -, low: +, moderate: ++, high: +++; Table A: 
first approach of transfection. Table B: Repetition of transfections with suboptimal performance 
scores, double amounts of plasmids used. 
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4.3 Analysis of LMH cells stably expressing various mNG-UL47 fusion proteins 
A subset of stably transduced LMH cells was fixed with PFA and nuclei were stained with 
DAPI. These cells were examined for the expression and localization of the mNG-UL47 
fusion proteins (Fig. 16). 
 
LMH cells:  
Native LMH cells served as negative control. No neon green fluorescence was detectable 
besides some blurred background or auto-fluorescence. 
mNG-N1:  
Neon green fluorescence was detectable mainly within the nuclei and and with lower 
intensity also in the cytosol. 
mNG-UL47_1-75: 
No green fluorescence signal was detectable (data not shown). Therefore, the construct was 
not used for further investigation 
mNG-UL47_60-155:  
Neon green fluorescence was detectable within the nuclei and with similar intensity also in 
the cytosol. 
mNG-UL47_140-245:  
A faint neon green fluorescence was detectable within the nuclei and the cytoplasm. 
Noticeable, bright fluorescent spots appeared in close proximity to the nuclei.  
mNG-UL47_230-335:  
Neon green fluorescence was detectable within the nuclei and with similar intensity also in 
the cytosol. 
mNG-UL47_321-430:  
Very few cells showed a fluorescent signal in form of very bright distinct spots.  
mNG-UL47_380-470:  
Neon green fluorescence was detectable within the nuclei and very bright distinct spots were 
observed in the cytosol, like they were detected for mNG-UL47_321-430. 
mNG-UL47_456-555:  
Neon green fluorescence was detectable within the nuclei and the cytosol. Furthermore, very 
bright distinct spots were observed in the cytosol, similar to those detected for mNG-
UL47_321-430. 
mNG-UL47_540-622:  
Neon green fluorescence was detectable mainly within the nuclei. 
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Neon green fluorescence DAPI counterstain Merged images 
LMH cells 
   
construct pL-mNG-N1 
   
construct pL-mNG-UL47_60-155 
   
construct pL-mNG-UL47_140-245 
   
construct pL-mNG-UL47_230-335 
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construct pL_mNG-UL47_321-430 
   
construct pL-mNG-UL47_380-470 
   
construct pL-mNG-UL47_456-555 
   
construct pL-mNG-UL47_540-622 
   
FIG. 16. Expression and localization of various mNG-UL47 fusion proteins.  
left: green – mNG or mNG-UL47 fusion proteins, middle: blue – DAPI, right: merge.           
60x magnification. Scale bar is 20 µm. 
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4.4 Western Blot 
The same blot was probed with two different antibodies. First with m-α-GFP and later with 
rab-α-UL47. With the GFP antibody, a moderate signal at the height of 32 kDa was detected 
exclusively in the lysates of the positive control EGFP-C1. The UL47 antibody revealed a 
strong signal in the range of the expected size (37 kDa) in samples of LMH cells transfected 
with an expression plasmid for mNG-UL47_60-155. Furthermore, two faint bands at around 
30-32 kDa appeared for the samples of LMH cells transfected with an expression plasmid for 
mNG-UL47_1-75 as well as for mNG-UL47_60-155 (Fig. 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 17. Western blot of lysates of transfected 239T cells.  
The blot was probed with with an GFP- and with an UL47- antibody. 
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4.5 Analysis of ILT reporter viruses 
Viral particles detected by the gJ-antibody should get detected in the red fluorescence 
channel. Those particles with incorporated mNG-UL47 fusion proteins should be detected in 
the green fluorescence channel. Co-localization should appear as yellow spots after merging 
both images (Fig. 18, Table 21). 
 
 
 
Transgene mNG-UL47 (green) ILT particles (red) Co-localization 
- - +++ - 
mNG -/+ ++/+++ - 
mNG-UL47_ 60-155 + ++ - 
mNG-UL47_ 140-245 - ++ - 
mNG-UL47_ 230-335 - +/++ - 
mNG-UL47_ 321-430 + ++ - 
mNG-UL47_ 380-470 + ++ - 
mNG-UL47_ 456-555 -/+ ++ - 
mNG-UL47_ 540-622 + ++ - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 21. Analysis of ILT reporter viruses. 
The amount of fluorescent spots subjectively rated with following scores: negative: -, low: +, 
moderate: ++, high: +++ 
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Neon green  ILTV particle stain (gJ) Merged images 
LMH cells 
  
 
construct pL-mNG 
   
construct pL-mNG-UL47_60-155 
   
construct pL-mNG-UL47_140-245 
  
 
construct pL-mNG-UL47_230-335 
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construct pL-mNG-UL47_321-430 
   
construct pL-mNG-UL47_380-470 
   
construct pL-mNG-UL47_456-555 
  
 
construct pL-mNG-UL47_540-622 
   
 
 
 
 
FIG. 18. ILT reporter viruses generated in mNG-UL47 expressing LMH cells. 
left: green – mNG or mNG-UL47 fusion proteins, middle: red – gJ antibody stain for detection 
of ILTV, right: merge. 100x magnification. 
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5. Discussion 
ILT is a worldwide distributed disease with an immense economical impact. Nowadays, still 
no effective vaccine, which delivers sufficient protection without leading to latent infection 
nor intermittent virus shedding, is developed. In addition, treatment of the disease is 
impossible. Thus, it is crucial to gain more insight into the virus life cycle. Reporter viruses 
serve as useful tools for studying virus-host interactions. With fluorescent-labelled viruses 
even real-time monitoring of several infection steps is possible. Therefore, the generation of 
ILT reporter viruses was anticipated. 
 
The assumption of a potential packaging signal at the C-terminal end of the UL47 gene of 
ILTV is based on the recent work of Schlegel and Blaho 2009 and alignment of HSV-1 VP22 
and ILTV UL47. This led to the generation of different mNG-UL47 fusion proteins to enable 
incorporation of mNG into virus particles. If the initially predicted C-terminal part of UL47 
would not be responsible for protein packaging, another part of the ILTV UL47 gene might 
enable the incorporation. Fragmentation of the UL47 gene was required, since the entire 
UL47 gene was to large to be successfully fused to mNG and inserted into the expression 
vector.  
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5.1 Cloning of mNG-UL47 fusion protein transfer vectors 
The amplification and fusion of the respective DNA fragments was successful as shown by 
agarose gel electrophoresis. Unclear bands or multiple signals resulting from non-specific 
amplifications were eliminated by adjusting the cycler program by a modification of the 
annealing temperature by 2°C. The weak bands around 300 – 400 bp detected after PCR 2 are 
remaining input DNA. Since the correct bands were excised from the gel, these additional 
bands had no impact on the following cloning reactions. Finally, PCR products of all 
intended fusion fragments have been produced.  
 
Upon ligation of the mNG-UL47 fusion fragments into the expression vector pL-EGFP-N1, 
the following transformation was performed in E. coli TOP 10 F’ and E. coli XL-10 gold. 
The reason for the use of two Escherichia coli strains was the low efficiency of the 
transformation of pL-mNG-N1 and pL-mNG-UL47_610-622 in the first two approaches 
using E. coli TOP 10 F’ (data not shown). Transformation of pL-mNG-UL47_140-245, pL-
mNG-UL47_230-335, pL-mNG-UL47_321-430, pL-mNG-UL47_380-470, pL-mNG-
UL47_456-555 and pL-mNG-UL47_540-622 into E. coli TOP 10 F’ resulted in properly 
grown colonies. The transformation of pL-mNG-N1, pL-mNG-UL47_610-622, pL-mNG-
UL47_1-75, and mNG-UL47_60-155 into E. coli XL-10 gold resulted in the growth of an 
appropriate amount of colonies to be picked for further plasmid preparation, control 
restriction analysis and subsequent sequencing. E. coli XL-10 gold support the amplification 
of large plasmids which might explain the better performance of some of the transformations 
compared to the previous approach in E. coli TOP 10 F’. 
 
After control restriction analysis, samples which showed the expected band pattern were 
sequenced. Eight out of nine constructs contained the correct amino acid sequences. Cloning 
of pL-mNG-UL47_610-622 was not successful. One explanation could be an incorrect 
primer. The used primers also encoded for restriction sites that were used for cloning. In rare 
events, point mutations can occur during primer synthesis. This could explain the 
unsuccessful insertion into the expression vector.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56 
5.2 Transfection of 293T cells and generation of retroviral vectors 
For the generation of retroviral vectors, 293T cells were transfected with a packaging 
construct, an envelope construct and the newly generated mNG-UL47 fusion fragment 
transfer vectors. The transfection efficiency could easily be monitored by the fluorescence of 
the mNG. Three constructs (pL-mNG-UL47_1-75, pL-mNG-UL47_140-245, and pL-mNG-
UL47_456-555) showed very few and/or weak fluorescence. Thus, the transfection was 
repeated with twice the amount of plasmid, which could improve the result slightly. The 
reasons for these heterogenous results are difficult to figure out. Transfection experiments 
were proceeded in parallel and positive and negative controls showed the expected results. 
Major errors on the part of utilized instruments and reagents or on the part of technical 
aspects as preparation of 293T cells, can thereby be excluded. 293T cells are suitable and 
designated as highly transfectable cell lines [44]. The consideration of the optimal density of 
the cells before transfection, appropriate cell culture medium and cell cultivation affirm a 
careful and precise workflow. No contamination of transfected cells, especially with 
Mycoplasma sp. which would alter the cell morphology, could be detected at any time of the 
experiments. Another conceivable reason for the partially poor transfection efficiency could 
be due to degradation of the plasmid DNA. Therefore, control restriction analysis was 
performed and resulted in distinct bands as described in the previous chapter. For degraded 
DNA a smear would have been expected. Furthermore, only plasmids with the correct mNG-
UL47 sequence were used. Since only the inserted mNG-UL47 region was sequenced, 
mutations in other parts of the plasmid, e.g. the promoter region, that might have occurred 
during the cloning process, remain possible. But the most likely reason for these results is an 
influence of the particular fused UL47 fragment on folding and/or localization of mNG which 
might have a negative effect on the fluorescence. 
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5.3 Transduction of LMH cells and generation of stable cell lines 
Analysis of the negative control (native LMH cells) revealed a dim, blurry fluorescence due 
to autofluorescence. In the positive control (LMH cells transduced with the mNG transfer 
vector) bright fluorescent nuclei were detected but also some weaker fluorescence was 
observed in the cytosol. mNG-UL47_60-155 and mNG-UL47_230-335 appeared equally 
distributed within the nucleus and cytoplasm. mNG-UL47_540-622 showed a pronounced 
signal in the nuclei similar to mNG alone. In cells expressing mNG-UL47_140-245 bright 
fluorescent spots were detected in close proximity to the nucleus. This localization could 
resemble the Golgi apparatus. A counterstain of a Golgi marker, e.g. E1A could verify this 
assumption. mNG-UL47_321-430, mNG-UL47_380-470 and mNG-UL47_456-555 also 
showed a distinct spotted fluorescence pattern but in contrast to mNG-UL47_140-245 it was 
more dispersed over the cytosol. This localization probably corresponds to cellular vesicles 
like endo- and exosomes, lysosomes or peroxisomes [45]. Again, a specific antibody stain of 
the particular organelles would be needed for an in depth analysis of the exact localization.  
 
ILTV UL47 was already shown to be localized within the cell nuclei as well as within the 
cytoplasm of infected chicken embryo kidney (CEK) cells [36]. This corresponds to the the 
fluorescent pattern observed for mNG-UL47_60-155 and mNG-UL47_230-335 and partially 
also for mNG-UL47_540-622, even though we used LMH cells. Furthermore, it was shown 
that the intracellular localization of a HSV-1 protein differs, dependent on the fused 
fluorescent protein [46]. In the presented work, the fused protein fragments influence the 
subcellular localization of the fluorescent protein. Thus, the UL47 fragments fused to mNG 
might contain motives that direct or retain the fusion protein to or in particular cell 
compartments. 
 
It was striking that the total amount of fluorescent cells was rather low. Especially, since the 
cells were selected for their antibiotic resistance which was transferred on the same construct 
as the mNG-UL47 fusion fragments. However, both genes are expressed under the control of 
different promoters. The antibiotic resistance is driven by the promoter of the Moloney 
murine leukemia virus whereas the expression of the mNG-UL47 fusion fragments is under 
the control of the cytomegalovirus promoter. It could be, that there is a CMV promoter 
specific silencing mechanism in LMH cells which leads to the downregulation of mNG-
UL47 fusion fragment expression or completely abolishes its expression. Nevertheless, a 
subset of cells showed clearly detectable fluorescent signals which differs in their patterns. 
 
A certain correlation between fluorescence detected after transfection and fluorescence 
visualized after transduction was observed. mNG-UL47_1-75 which did not emit any 
fluorescence after transduction was already one of the weakest mNG-UL47 fusion fragments 
after transfection. mNG-UL47_140-245 which delivered a low to moderate fluorescence 
performance after transfection delivered consecutively weak signals after transduction. 
However, mNG-UL47_321-430 showed high fluorescence after transfection but very weak 
fluorescence after transduction with only very few cells showing a fluorescent signal in form 
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of very bright distinct spots. This might be a cell line specific effect, since human 293T cells 
were used for generating the retroviral vectors and chicken LMH cells for the transduction. 
 
 
 
5.4 Western blot 
To test the expression of the newly generated mNG-UL47 fusion fragments the fluorescence 
upon transfection was monitored. With this technique, it cannot be differentiated between 
protein size. Thus, a Western blot analysis was anticipated, since this method allows the 
discrimination between different sizes. All fusion proteins contain the full length mNG and 
therefore an antibody against mNG would have been feasible. However, so far no antibody 
specific for mNG is available. Since mNG shares some nucleotide (53%) as well as amino 
acid (33%) homology to EGFP, an antibody against GFP was tested. Unfortunately, the 
antibody does not recognize mNG only EGFP as seen for the control EGFP-C1. Albeit, the 
fusion proteins only contain parts of UL47, an antibody against this protein was utilized to 
detect the fusion proteins. Using this antibody mNG-UL47_60-155 could be visualized, what 
leads to the assumption that the epitope recognized by the UL47 antibody is encoded within 
the amino acids 60-155. Worth mentioning is the fact, that a second much weaker band at a 
lower molecular weight, occurred exclusively for mNG-UL47_60-155 and for mNG-
UL47_1-75 but for non of the other fusion proteins. This makes it unlikely to be completely 
unspecific. Since there is an overlap of 15 amino acids between mNG-UL47_60-155 and 
mNG-UL47_1-75, the epitope can most likely pinpointed to this area. The weak, smaller 
band in the lane of mNG-UL47_60-155 might represent a cleavage product (Fig. 19).  
 
 
It was finally not possible to detect all mNG-UL47 fusion proteins by Western blot analysis. 
But since all cloning products have been sequenced and fluorescence was visible, it is very 
likely that the anticipated constructs were generated. 
FIG. 19. Proposed antibody recognition site (   ) and protein cleavage site (   ) 
Y 
✂
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5.5 Generation of ILT reporter viruses 
By infecting the mNG-UL47 fusion protein expressing cell lines with a mutant ILTV lacking 
the UL47 gene, it was anticipated to achieve the incorporation of mNG into the newly 
generated ILTV particles due to the putative packaging signal of the fused UL47 fragment. 
This could not be shown for any of the generated fusion proteins. In some cases, (mNG-
UL47_60-155, mNG-UL47_321-430, mNG-UL47_380-470, mNG-UL47_540-622) 
fluorescent spots were detected in the green channel. But since these spots do not co-localize 
with the immuno-stained ILTV particles (visible in the red channel), it is likely that these 
spots are artefacts and result from non-virus associated mNG protein aggregates. An often 
occurring issue with packaging heterologous proteins into virus capsids is the size and thus 
sterical hindrance. This is unlikely, since the mutant virus does not contain the wild type 
protein and the mNG-UL47 fusion proteins are not bigger than the original UL47 protein. A 
possible explanation for not detecting any incorporated mNG-UL47 fusion-protein, is the 
missing VPS. Maybe, in case of ILTV UL47, this signal is not only an amino acid sequence 
but a tertiary protein structure, which might involve several different domains. Another 
reason could be an intensity issue. Even if mNG is the brightest fluorescent protein currently 
available, the packaged amount might be to small to be recognized with a standard 
fluorescence microscope. Furthermore, the cellular localization of the protein might be 
important for packaging into the virus particle. Some of the observed fluorescent patterns 
could indicate an association of the respective protein to a particular cellular organelle, which 
might prevent packaging. Another reason for the not succeeded incorporation of the mNG-
UL47 fusion proteins could be the phosphorylation status of the protein. For several HSV-1 
tegument proteins it was shown, that only underphosphorylated versions are incorporated into 
virus particles [47], [48], [49]. Besides a particular packaging sequence and the 
phosphorylation status the interaction with other viral proteins might be needed for successful 
incorporation into virus particles as it was also shown for ICP0 another HSV-1 protein [50]. 
 
 
 
5.6 Conclusions 
The aim of this study was the generation of ILT reporter viruses with incorporated 
mNeonGreen-UL47 fusion proteins. Cloning of the various mNG-UL47 fusion fragments, 
transfection of 293T cells and further transduction of LMH cells was successfully 
implemented in at least seven out of initially nine samples. The final goal of generating ILT 
reporter viruses was not succeeded. The assumed virion packaging signal, a motif of six 
consecutive amino acids which is similar to the one found in VP22 of HSV-1, could not be 
proven to exist or function in ILTV UL47.  
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8.  Appendix 
8.1 Index of abbreviations 
°C degree Celsius 
293T Human embryonic kidney (cell line) 
  
bp base pairs 
  
c-terminal carboxy-terminal 
CEK chicken embryo kidney (cell line) 
cm centimetre 
cm2 square centimetre 
CMV cytomegalovirus 
cs coverslip 
  
DAPI 4',6-diamidino-2-phenylindole 
dATP deoxyadenosine triphosphate 
DC direct current 
ddH2O double-distilled water 
DIC differential interference contrast 
DIVA Differentiating Infected from Vaccinated Animals 
DMEM Dulbecco’s Modified Eagle Medium 
DNA deoxyribonucleic acid 
dNTP deoxynucleoside triphosphate 
  
E. coli Escherichia coli 
E1A adenoviral early region 1A 
ECL enhanced chemiluminescence 
EDTA ethylenediaminetetraacetic acid 
EGFP enhanced green fluorescent protein 
EtBr ethidium bromide 
  
FBS fetal bovine serum 
  
g g-force / relative centrifugal force 
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G418 Geneticin 
GaHV-1 gallid herpesvirus 1 
GFP green fluorescent protein 
gJ glycoprotein J 
  
h hour 
HSV-1 herpes simplex virus 1 
HSV-2 herpes simplex virus 2 
  
ILT infectious laryngotracheitis 
ILTV infectious laryngotracheitis virus 
  
kb kilo base pairs 
kDa kilodalton 
  
LMH Leghorn Male Hepatoma (cell line) 
LTR long terminal repeat 
  
MDV-1 Marek’s disease virus serotype 1 
mg milligram 
min minute 
ml millilitre 
mM millimolar 
mNG monomeric NeonGreen 
  
NeoR Neomycin resistance gene 
ng nanogram 
  
ORF open reading frame 
  
P/S Penicillin-Streptomycin 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PES polyethersulfone 
PFA paraformaldehyde 
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PrV pseudorabies virus 
PsHV-1 psittacid herpes virus 1 
  
qPCR real-time polymerase chain reaction 
  
RFP red fluorescent protein 
rpm revolutions per minute 
RT room temperature 
  
s second 
SN supernatant 
sp. species 
  
TAE Tris-Acetat-EDTA 
TBS Tris-buffered saline 
TTBS TBS containing Tween20 
  
UL unique long 
US unique short 
  
V volt 
VPS virion packaging signal 
VZV Varicella zoster virus 
  
wt wild type 
  
µg microgram 
µl microliter 
µm micrometre 
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